BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Immunology Podcast - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.immunologypodcast.com
X-WR-CALDESC:Events for The Immunology Podcast
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260417T110000
DTEND;TZID=America/New_York:20260417T120000
DTSTAMP:20260302T165757Z
CREATED:20260302T165757Z
LAST-MODIFIED:20260302T165757Z
UID:6457-1776423600-1776427200@www.immunologypodcast.com
SUMMARY:Live Show: Emerging Immunotherapies for Solid Tumors
DESCRIPTION:Join the Immunology Podcast for a live recording on emerging immunotherapies for solid tumors at IMMUNOLOGY2026™. Hosts Brenda Raud and Jason Goldsmith will be joined by Dr. Charles Sentman\, Director of the Center for Synthetic Immunity at Dartmouth College\, and Dr. Giulia Escobar\, Director of Pre-Clinical Research at Massachusetts General Hospital. Together\, they’ll explore new strategies aimed at overcoming the unique challenges of treating solid tumors\, from engineering more effective immune cells to navigating the tumor microenvironment. The discussion will highlight recent advances in preclinical and translational research and what they could mean for the future of cancer immunotherapy. \nDate: Friday\, April 17\, 2026\nTime: 11:00 – 12:00 pm\nLocation: Thomas M. Menino Convention & Exhibition Center\, Room 157AB
URL:https://www.immunologypodcast.com/upcoming-guests/live-show-emerging-immunotherapies-for-solid-tumors
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2026/03/Charles-Sentman-and-Giulia-Escobar.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260908
DTEND;VALUE=DATE:20260909
DTSTAMP:20260901T180602Z
CREATED:20260901T180602Z
LAST-MODIFIED:20260901T180602Z
UID:6682-1788825600-1788911999@www.immunologypodcast.com
SUMMARY:Dr. Martin Prlic
DESCRIPTION:Dr. Martin Prlic is a Professor in the Vaccine and Infectious Disease Division at Fred Hutch Cancer Center. He discusses the challenges of studying human immunology and how his lab uses advanced single-cell technologies to understand T cell responses across healthy\, inflamed\, and tumor tissues. He also explores the biology of tissue-resident T cells\, how inflammation shapes their function\, and immune cell interactions at the maternal-fetal interface.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-martin-prlic
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2026/08/Prlic-Martin_square-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260922
DTEND;VALUE=DATE:20260923
DTSTAMP:20260921T201857Z
CREATED:20260918T183334Z
LAST-MODIFIED:20260921T201857Z
UID:6697-1790035200-1790121599@www.immunologypodcast.com
SUMMARY:Dr. Roger Geiger
DESCRIPTION:Dr. Roger Geiger is a Group Leader at the Institute for Research in Biomedicine in Bellinzona\, Switzerland\, and leads a research group at the Technical University of Dresden in Germany. He discusses how his lab studies the metabolic regulation of T cell function and explores engineering bacteria to deliver therapeutic payloads directly to tumors. He also explains how arginine metabolism can enhance anti-tumor T cell responses and how naïve T cells remain metabolically prepared to rapidly respond to immune challenges.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-roger-geiger
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2026/09/ChatGPT-Image-Sep-14-2026-11_32_45-AM-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261006
DTEND;VALUE=DATE:20261007
DTSTAMP:20260921T201837Z
CREATED:20260921T201837Z
LAST-MODIFIED:20260921T201837Z
UID:6709-1791244800-1791331199@www.immunologypodcast.com
SUMMARY:Dr. Merav Cohen
DESCRIPTION:Dr. Merav Cohen is a Principal Investigator at Tel Aviv University. She discusses how her lab uses single-cell technologies to decode communication between immune cells and their surrounding tissues. She explores how physical interactions can reprogram macrophages and neutrophils\, how these cells communicate with tumor cells\, and how cellular crosstalk can promote angiogenesis\, tumor growth\, and cancer progression.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-merav-cohen
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2026/09/Merav_Cohen_square-1.jpg
END:VEVENT
END:VCALENDAR